• Events


    BDO events bring our community together in an online and offline setting
    to connect with each other and share insights into the topics and trends.

BDO’s Panel Trifecta at the Annual JP Morgan Healthcare Conference

January 10, 2018
8:30 AM to 1:00 PM PST

Four Seasons Hotel San Francisco - Yerba Buena Room
757 Market Street
San Francisco, CA 94103
get directions

Daphne Goldfarb
(212) 885-7240
Email
  • Summary
  • Agenda
At the corner of innovation and investment.

Make no mistake, disruption is the new normal in healthcare. Join us for an intimate summit of top execs in biotech, pharma, private equity, venture capital and more to unpack three of the industry’s biggest head-scratchers:
  • Breakfast Session Panel: Finding the Right Dose of Portfolio Mix
  • Mid Morning Session Panel: Adjusting to Disruption: The ‘New Normal’ in Healthcare?
  • Lunch Session Panel: Money-based guarantee: The next drug pricing model?
8:30 AM to 9:30 AM - Breakfast Panel Topic: Finding the Right Dose of Portfolio Risk
New drug development, genomic therapies, precision medicine and personalized care are fantastic developments in healthcare—but ultimately, they must drive business value and financial performance for investors. Innovative treatments raise financial, business model, operational, societal and ethical questions. How do you know whether they're driving value that's worth investment? This session will discuss how to balance your portfolio by finding the right "dose" of innovation—identifying investments that advance discoveries of new, effective drugs and treatments, while keeping an eye on efficacy, access and cost. 

BDO Moderator:
Steven Shill, CPA, Partner & National Healthcare Leader

Panelists:
Ira Coleman, JD, Chairman & Partner, McDermott, Will & Emery
Christopher W. Kersey, MD, MBA, Founding Managing Partner, Havencrest Healthcare Partners
Bert Nortini, JD, Managing Director, New Mountain Capital
 

10:30 AM to 11:30 AM - Mid-Morning Panel Topic: Adjusting to Disruption: The 'New Normal' in Healthcare?
Today, disruption—technological advancements like artificial intelligence and genomic mapping, and the growth of wearable technology and telemedicine—is bringing greater focus on non-traditional health companies for wellness and prevention. Technologies like the Apple Watch are working their way through the FDA approval process for preventative applications and detection, which could shrink Medicare and Medicaid spending around the treatment of certain conditions in the future. The FDA's Software PreCert Pilot Program, aiming to fast-track the approval process for medical software products like those of Apple and Fitbit, is opening new avenues for industry innovation.

For traditional providers, the time to move on this trend is now. Collaborating in innovative ways with disruptors grows the potential for smarter, more effective treatment across the care continuum and better healthcare outcomes. In this session, we'll hear how new products are paving the way for startups and traditional providers to better meet the needs of today's empowered consumers, and what other areas of healthcare are ripe for disruption. 

BDO Moderator:
Patrick Pilch, CPA, MBA, Managing Director & National Healthcare Advisory Leader 

Panelists:
Lisa Alderson, MBA, CEO & Co-Founder Genome Medical
Martin Kelly, MBA, Co-Founder & CEO, Health XL
Lee Jones, President and CEO, Rebiotix
William Payne, MD, Founder, myowndoctor.com
 
 

12:00 PM to 1:00 PM - Lunch Panel Topic:  Money-based Guarantee: The Next Drug Pricing Model?
Deciding which treatment options to prescribe a patient? There's a database for that. Providers are using real-time clinical data to provide better quality of care to their patients through treatment options that are based on efficacy and outcomes—and their reimbursement levels depend on it. As the U.S. healthcare industry shifts to value-based reimbursement models, it's creating a catalyst to outcomes-based drug pricing. Clinical proof, once a sufficient foundation for a drug's success, is no longer enough. If drug manufacturers are to stay competitive in the new healthcare environment while reconciling pricing pressures, they must follow healthcare's lead and add demonstration of efficacy to their formula for success.

BDO Moderator:
David Friend, MD, MBA, Chief Transformation Officer, BDO Center of Healthcare Excellence & Innovation
 
Panelists:
Ann Kraft, MBA, Executive Director, Purdue Pharma 
Steven L. Small, PhD, MD, Professor and Chair, Department of Neurology, UC Irvine School of Medicine